NCT07195071 - Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer Screening | Biotech Hunter

Enrollment

1,000

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Hereditary Cancer Syndrome

Interventions

DEVICE

Natera empower comprehensive hereditary cancer panel

Natera Empower Comprehensive Hereditary Cancer Panel to screen for hereditary cancers

DEVICE

Obstetrical carrier screening

Obstetrical carrier screening for genetic conditions

Trial Locations (1)

Columbia University Irving Medical Center, New York